Detalhe da pesquisa
1.
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO.
Ann Oncol
; 31(3): 334-351, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32067677
2.
Efficacy and safety findings from DREAM: a phase III study of DHP107 (oral paclitaxel) versus i.v. paclitaxel in patients with advanced gastric cancer after failure of first-line chemotherapy.
Ann Oncol
; 29(5): 1220-1226, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29438463
3.
Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma.
Ann Oncol
; 29(6): 1402-1408, 2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29659672
4.
Comparison of two different S-1 plus cisplatin dosing schedules as first-line chemotherapy for metastatic and/or recurrent gastric cancer: a multicenter, randomized phase III trial (SOS).
Ann Oncol
; 26(10): 2097-101, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26216386
5.
Analysis of serum protein biomarkers, circulating tumor DNA, and dovitinib activity in patients with tyrosine kinase inhibitor-refractory gastrointestinal stromal tumors.
Ann Oncol
; 25(11): 2272-2277, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25149706
6.
Phase II study of dovitinib in patients with metastatic and/or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib.
Br J Cancer
; 109(9): 2309-15, 2013 Oct 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-24084771
7.
Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum.
Br J Cancer
; 106(6): 1039-44, 2012 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-22343617
8.
Sorafenib in patients with metastatic gastrointestinal stromal tumors who failed two or more prior tyrosine kinase inhibitors: a phase II study of Korean gastrointestinal stromal tumors study group.
Invest New Drugs
; 30(6): 2377-83, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22270258
9.
Tumor immune-gene expression profiles and peripheral immune phenotypes associated with clinical outcomes of locally advanced pancreatic cancer following FOLFIRINOX.
ESMO Open
; 7(3): 100484, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35576696
10.
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis.
ESMO Open
; 7(6): 100591, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36208496
11.
Capecitabine plus temozolomide in patients with grade 3 unresectable or metastatic gastroenteropancreatic neuroendocrine neoplasms with Ki-67 index <55%: single-arm phase II study.
ESMO Open
; 6(3): 100119, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33901869
12.
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Br J Cancer
; 99(4): 584-90, 2008 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-18665164
13.
Phase I study of proteasome inhibitor bortezomib plus CHOP in patients with advanced, aggressive T-cell or NK/T-cell lymphoma.
Ann Oncol
; 19(12): 2079-83, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18689866
14.
Belotecan, new camptothecin analogue, is active in patients with small-cell lung cancer: results of a multicenter early phase II study.
Ann Oncol
; 19(1): 123-7, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17823384
15.
Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group.
Ann Oncol
; 19(8): 1477-1484, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18385201
16.
High-dose chemotherapy with autologous stem cell transplantation in extranodal NK/T-cell lymphoma: a retrospective comparison with non-transplantation cases.
Bone Marrow Transplant
; 37(9): 819-24, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16547486
17.
A phase II trial of DA-125, a novel anthracycline, in advanced non-small-cell lung cancer.
Cancer Chemother Pharmacol
; 44(6): 518-21, 1999.
Artigo
em Inglês
| MEDLINE | ID: mdl-10550574
18.
Adjuvant (cisplatin, etoposide, and 5-fluorouracil) chemotherapy after curative resection of gastric adenocarcinomas involving the esophagogastric junction.
Am J Clin Oncol
; 22(3): 253-7, 1999 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-10362331
19.
Ramosetron for the prevention of cisplatin-induced acute emesis: a prospective randomized comparison with granisetron.
J Int Med Res
; 30(3): 220-9, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12166338
20.
Prognostic significance of p53 gene mutations and protein overexpression in localized gastrointestinal stromal tumours.
Histopathology
; 51(3): 379-89, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17727479